stoxline Quote Chart Rank Option Currency Glossary
BlackRock Health Sciences Trust (BME)
38.61  0.13 (0.34%)    12-01 16:00
Open: 38.5
High: 38.76
Volume: 71,062
Pre. Close: 38.48
Low: 38.38
Market Cap: 538(M)
Technical analysis
2023-12-01 4:18:38 PM
Short term     
Mid term     
Targets 6-month :  45.27 1-year :  52.87
Resists First :  38.75 Second :  45.27
Pivot price 37.81
Supports First :  36.76 Second :  35.52
MAs MA(5) :  38.18 MA(20) :  37.74
MA(100) :  38.89 MA(250) :  40.61
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  88.4 D(3) :  80.4
RSI RSI(14): 63.9
52-week High :  45.04 Low :  35.52
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ BME ] has closed above the upper band by 1.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 0.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 38.52 - 38.66 38.66 - 38.83
Low: 37.55 - 37.71 37.71 - 37.9
Close: 38.18 - 38.44 38.44 - 38.74
Company Description

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Headline News

Thu, 30 Nov 2023
Certain BlackRock Closed-End Funds Announce Estimated Sources ... - Business Wire

Thu, 30 Nov 2023
ETF vs. Investment Trust: What's the Difference? - Investopedia

Sun, 15 Oct 2023
4 Closed-End Fund Buys In The Month Of September 2023 - Seeking Alpha

Thu, 28 Sep 2023
BMEZ CEF: The Discount Widens As BlackRock Changes Its ... - Seeking Alpha

Sun, 17 Sep 2023
BME: Blackrock's Health Sciences Fund Is A Solid Alternative To ... - Seeking Alpha

Mon, 03 Jul 2023
Distribution Dates and Amounts Announced for Certain BlackRock ... - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Financial Services
Asset Management
Shares Out 14 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 18.2 (%)
Shares Short 8 (K)
Shares Short P.Month 28 (K)
Stock Financials
EPS 3.44
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 42.83
Profit Margin 572.8 %
Operating Margin 27.5 %
Return on Assets (ttm) 0.2 %
Return on Equity (ttm) 8.1 %
Qtrly Rev. Growth 13.1 %
Gross Profit (p.s.) 0.55
Sales Per Share 0.59
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 15 (M)
Levered Free Cash Flow -1 (M)
Stock Valuations
PE Ratio 11.23
PEG Ratio 0
Price to Book value 0.9
Price to Sales 65.46
Price to Cash Flow 34.96
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android